DP
LMAT icon

Dundas Partners’s LeMaitre Vascular LMAT Stock Holding History

Dundas Partners’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$210K Sell
1,920
-1,326
-41% -$126K 0.02% 43
2025
Q4 		$263K Buy
3,246
+586
+22% +$50.4K 0.02% 46
2025
Q3 		$233K Hold
2,660
– – 0.02% 48
2025
Q2 		$221K Buy
+2,660
New +$222K 0.02% 47

Other funds holding LMAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Dundas Partners's LMAT Position: Q1 2026 in Review

Dundas Partners reduced its LeMaitre Vascular (LMAT) stake by 41% in Q1 2026, selling an estimated $126K and leaving 1,920 shares worth $210K. The position accounts for 0.02% of the portfolio, ranked #43.

Dundas Partners first reported a position in LMAT in Q2 2025 and has held it in 4 quarters since. The position peaked at $263K in Q4 2025. 339 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.

  • Dundas Partners held 1,920 shares of LeMaitre Vascular worth $210K as of Q1 2026.
  • Dundas Partners sold 1,326 LeMaitre Vascular shares in Q1 2026, an estimated $126K.
  • LeMaitre Vascular made up 0.02% of Dundas Partners's portfolio in Q1 2026, its #43 holding.
  • Dundas Partners first reported a position in LeMaitre Vascular in Q2 2025 and has held it in 4 quarters since.
  • Dundas Partners's LeMaitre Vascular position peaked at $263K in Q4 2025.
  • 339 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.

Based on Dundas Partners's 13F filing for Q1 2026, filed 14 May 2026.